These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6190875)

  • 41. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
    Sheth HB; Glasier LM; Ellert NW; Cachia P; Kohn W; Lee KK; Paranchych W; Hodges RS; Irvin RT
    Biomed Pept Proteins Nucleic Acids; 1995; 1(3):141-8. PubMed ID: 9346845
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Feasibility of prophylaxis and therapy against gram-negative infections by human monoclonal antibodies.
    Lang AB; Fürer E; Cryz SJ
    FEMS Immunol Med Microbiol; 1993 Jun; 7(1):9-13. PubMed ID: 8364527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
    Zaidi TS; Priebe GP; Pier GB
    Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidemiology of nosocomial infection due to Gram-negative bacilli: aspects relevant to development and use of vaccines.
    Stamm WE; Martin SM; Bennett JV
    J Infect Dis; 1977 Aug; 136 Suppl():S151-60. PubMed ID: 330774
    [No Abstract]   [Full Text] [Related]  

  • 45. Pseudomonas aeruginosa vaccine in cancer patients.
    Young LS; Meyer RD; Armstrong D
    Ann Intern Med; 1973 Oct; 79(4):518-27. PubMed ID: 4201225
    [No Abstract]   [Full Text] [Related]  

  • 46. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Passive immunisation against Pseudomonas aeruginosa recombinant flagellin in an experimental model of burn wound sepsis.
    Faezi S; Sattari M; Mahdavi M; Roudkenar MH
    Burns; 2011 Aug; 37(5):865-72. PubMed ID: 21334822
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic, nasal and oral live vaccines against Pseudomonas aeruginosa: a clinical trial of immunogenicity in lower airways of human volunteers.
    Bumann D; Behre C; Behre K; Herz S; Gewecke B; Gessner JE; von Specht BU; Baumann U
    Vaccine; 2010 Jan; 28(3):707-13. PubMed ID: 19887136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia.
    Bhattacharjee AK; Opal SM; Taylor R; Naso R; Semenuk M; Zollinger WD; Moran EE; Young L; Hammack C; Sadoff JC; Cross AS
    J Infect Dis; 1996 May; 173(5):1157-63. PubMed ID: 8627067
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Therapy and prevention of Pseudomonas infection. A symposium. 25-27 September 1986, Herrsching/Ammersee. Proceedings].
    Infection; 1987; 15(1):46-84. PubMed ID: 3570484
    [No Abstract]   [Full Text] [Related]  

  • 51. Control of infection with gram-negative bacteria in patients at special risk.
    Lowbury EJ
    Proc R Soc Med; 1971 Sep; 64(9):986-8. PubMed ID: 5000382
    [No Abstract]   [Full Text] [Related]  

  • 52. Passive protection against heterologous gram-negative bacteria mediated by antiserum to epimeraseless Rc mutant of Salmonella minnesota.
    Konstantinov G; Karacholeva M; Eskenazy M; Ivanova R; Vassileva J; Naumova F; Tekelieva R; Strahilov D
    Ann Immunol (Paris); 1982; 133D(1):71-6. PubMed ID: 6760795
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapy of nosocomial infections: past, present and future trends.
    Pasko M; Beam TR
    J Med; 1980; 11(4):303-15. PubMed ID: 6943262
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Therapy and prevention of Pseudomonas infection. II. A symposium. 25-27 September 1986, Herrsching/Ammersee. Proceedings].
    Infection; 1987; 15(2):133-52. PubMed ID: 3596811
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunoprophylaxis of Pseudomonas aeruginosa.
    Young LS; Armstrong D; Markley K
    Ann Intern Med; 1971 Jun; 74(6):1012-3. PubMed ID: 4996343
    [No Abstract]   [Full Text] [Related]  

  • 56. [Evaluation of the specific activity of hyperimmune anti-Pseudomonas aeruginosa human plasma in an experiment].
    Podgornaia LG; Shinkarenko AA; Krokhina MA; Dziuban NF; D'iachenko VF
    Patol Fiziol Eksp Ter; 1987; (2):70-2. PubMed ID: 3112715
    [No Abstract]   [Full Text] [Related]  

  • 57. Efficacy of ribosomal preparations from Pseudomonas aeruginosa to protect against intravenous Pseudomonas challenge in mice.
    Smith RL; Wysocki JA; Bruun JN; De Courcy SJ; Blakemore WS; Mudd S
    J Reticuloendothel Soc; 1974 Jan; 15(1):22-30. PubMed ID: 4204145
    [No Abstract]   [Full Text] [Related]  

  • 58. Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study Group.
    Donta ST; Peduzzi P; Cross AS; Sadoff J; Haakenson C; Cryz SJ; Kauffman C; Bradley S; Gafford G; Elliston D; Beam TR; John JF; Ribner B; Cantey R; Welsh CH; Ellison RT; Young EJ; Hamill RJ; Leaf H; Schein RM; Mulligan M; Johnson C; Abrutyn E; Griffiss JM; Slagle D
    J Infect Dis; 1996 Sep; 174(3):537-43. PubMed ID: 8769611
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vaccination against Pseudomonas infection in burned patients: aspects and problems.
    Taidelli G; Savani A; Grisotti A
    Acta Chir Plast; 1971; 13(2):94-9. PubMed ID: 4106415
    [No Abstract]   [Full Text] [Related]  

  • 60. The immunoprophylaxis and immunotherapy of Pseudomonas infections in burns with polyvalent Pseudomonas aeruginosa corpuscular vaccine.
    Ionescu A; Meitert E; Vasiliu S; Meitert T; Milicescu S; Sima F; Savulian C
    Arch Roum Pathol Exp Microbiol; 1979; 38(3-4):317-30. PubMed ID: 122594
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.